Showing results (21-30 of 191) with videos related to
Sort By:
Pageof 20
Transplantation and Cellular Therapy|September 2, 2021
Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous LeukemiaNicholas P Tschernia, Vaibhav Kumar, Dominic T Moore, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2016
A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian MetastasesAnne Montfort, Oliver Pearce, Eleni Maniati, et al.The Journal of Clinical Investigation|August 22, 2017
Treg depletion potentiates checkpoint inhibition in claudin-low breast cancerNicholas A Taylor, Sarah C Vick, Michael D Iglesia, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 29, 2013
Circulating fibrocytes prepare the lung for cancer metastasis by recruiting Ly-6C+ monocytes via CCL2Hendrik W van Deventer, Daniela A Palmieri, Qing Ping Wu, et al.Nature Nanotechnology|June 27, 2017
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapyYuanzeng Min, Kyle C Roche, Shaomin Tian, et al.Blood|May 28, 2017
T-cell expression of AhR inhibits the maintenance of pTreg cells in the gastrointestinal tract in acute GVHDTrisha A Dant, Kaifeng L Lin, Danny W Bruce, et al.Blood|January 4, 2003
Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1 alpha (CCL3) after allogeneic BMT in miceAngela Panoskaltsis-Mortari, John R Hermanson, Elizabeth Taras, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2017
Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune LandscapeHawazin Faruki, Gregory M Mayhew, Jonathan S Serody, et al.Scientific Reports|March 12, 2021
Targeted therapy of human leukemia xenografts in immunodeficient zebrafishRanganatha R Somasagara, Xiaoyan Huang, Chunyu Xu, et al.Cancer Investigation|February 15, 2011
Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myelomaAnne W Beaven, Dominic T Moore, Andrew Sharf, et al.Pageof 20